Ticker Symbol: LGND

Ligand Pharmaceuticals, Inc. - Class B

$161.47 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000886163

Company Profile

Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenx Inc., the company went public in 1992.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: 3911 Sorrento Valley Blvd Ste 110

Website: www.ligand.com

CEO: John Higgins

Tags:

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $58.75

Change: -$0.42 ( -0.71%)

Days Range: $58.21 - $59.40

Beta: -

52wk. High: $89.58

52wk. Low: $52.58

Ytd. Change -12.13%

50 Day Moving Average: $60.05

200 Day Moving Average: $69.04

Shares Outstanding: 17355257

Valuation

Market Cap: 102.0B

PE Ratio: 37.66

EPS (TTM): 1.56

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A